M Hepes buffer (HBSS). Mishell-Dutton medium
, freshly prepared and supplemented with 5 × 10 -5 M 2-mercaptoethanol and 2% heat-inactivated fetal calf serum (FCS) (Flow Laboratories, Inc., Rockville, Md.), was used throughout. Cytotoxicity assays were performed in cell culture medium fortified with 5% FCS.
Antisera. (A.TH × B10.HTT)F1 anti-A.TL serum, hereafter termed anti-Ia, was prepared by concanavalin A (Con A) thymocyte blast immunization as described by Hayes and Bach (12) . The method of Reif and Allen (13) was used to prepare anti-Thy-1.2 serum. Antisera were tested by a two-stage, dye-exclusion microcytotoxicity test (12) . Anti-Ia serum lysed >50% of A.TL lymph node cells, with half-maximal lysis at a 1:1,280 dilution. Anti-Thy-1.2 lysed >95% of C3H/HeJ thymocytes, with half-maximal lysis at a 1:640 dilution. Fresh guinea pig serum, obtained bimonthly by heart puncture, served as complement (C). For anti-Ia serum lysis of splenocytes, cells were suspended in HBSS-diluted antiserum (1.0 ml of 1:20/5 × 107 cells) and incubated on ice for 15 min. 10 vol of cold HBSS were added, the cells pelleted (1,000 rpm, 10 min), and resuspended in HBSS-diluted C (1.0 ml of 1:25/5 × 10 7 cells). After 30 min at 37°C, the cells were washed twice with HBSS and resuspended in culture medium. Cultured lymphocytes were lysed with anti-Thy-l.2 serum plus C according to the same protocol, except that serum was diluted 1:15, C was absorbed with mouse spleen cells (5 ml of 1:5-diluted C; 1 × 108 cells; 15 min on ice), and the treatment was repeated one additional time. For absorption experiments, HBSS-diluted anti-Ia serum (1.0 ml of 1:20) was absorbed twice (15 rain on ice) with either B 10.S or B10.BR splenocytes (1 × 108 cell/absorption).
Cell Counting. Cell viability was determined by trypan blue exclusion staining. Cell concentrations are expressed as viable cells per milliliter.
MLC. Responding splenocytes, either untreated or treated with antiserum and C, were suspended in culture medium and aliquoted into microtiter wells (5 × 105 cell/well) (No. 76-002-05, Linbro Chemical Co., Hamden, Conn.). X-irradiated (2,000 R), stimulating splenocytes, suspended in culture medium, were aliquoted into wells (5 × 105 cell/well). Total cell culture vol was 0.2 ml. In some experiments, 24-well culture plates (No. 76-033-05, Linbro Chemical Co.) were used (5 × 106 cells of each type; 2.0 ml). After 5-6 d at 37°C in a humidified atmosphere of 5% CO2 in air, replicate cultures were resuspended with a Pasteur pipet, pooled, washed with HBSS, and resuspended in fresh medium with 5% FCS (2.5 × 106 cell/ml) for cytotoxicity assay.
Cell-mediated Lympholysis Assay. Blast cell targets were prepared 48 h beforehand by adding Con A (2.5/Lg/ml; Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) to replicate cultures of splenocytes in medium with 5% FCS (15 × 106 cell/3 ml; 35 × 10-mm tissue culture dishes; No. 3001, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). To an aliquot of Con A-stimulated blast cells (5 × 106 cells in 0.3 ml HBSS with 5% FCS) was added Na2 ~1CrO4 (50 /~1 of 5 mCi/ml; New England Nuclear, Boston, Mass.), and the mixture was incubated at 37°C for 1 h, resuspending the cells at 15-min intervals. 5XCr-labeled cells, washed three times with HBSS, were resuspended in medium with 5% FCS at 5 × 104 cell/ml. 5XCr-release assays were performed in microtiter plates (No. 76-011-05, Linbro Chemical Co.). Appropriately diluted effector cell suspensions (0.1 ml) followed by ~]Cr-labeled target cells (0.1 ml) were dispensed into each of four replicate wells. Six replicate wells of medium and target cells served as background controls; six wells of detergent (0.5% Nonidet P40, Shell Oil Co., Houston, Tex.) and target cells gave maximal 51Cr-release values. Plates were centrifuged (250 g, 5 min) then incubated for 8 h at 37°C in a humidified atmosphere of CO2 in air. A 100-/xl sample was removed from each well and counted in a Packard 5320 auto gamma scintillation spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.).
Data Calculation, Presentation, and Statistical Evaluation. Percent specific 51Cr release was calculated for each replicate sample according to the formula: The anti-Ia serum used in these experiments has been extensively characterized with regard to its haplotype specificity (10) . Absorption results confirmed this specificity: B10.BR cells that remained after treatment with unabsorbed anti-Ia serum and (2 lysed (2BA targets (29.0 _ 8.7%) after being cultured 6 d in vitro with (2BA stimulating cells. When anti-Ia serum was first absorbed with B 10.BR or (23H spleen cells, Tc did not develop (-8.7 __. 7.3%). On the other hand, anti-Ia serum retained its reactivity after absorption with B10.S spleen cells (28.0 +_ 11.1%).
Discussion
The results presented in this paper demonstrate that responding cells that remain after anti-Ia serum and (2 treatment generate a highly significant cytotoxic response against non-MH(2 antigens: NMS and (2-treated control cells do not. The cytotoxic response appears to be antigen specific in that target cells of strains other than the sensitizing strain are not lysed, or lysed to a lesser extent. The cytotoxic cells are susceptible to anti-Thy-l.2 and (2 lysis. Thus, they appear to be To.
The anti-Ia serum employed in these studies has been well characterized with respect to its specificity (10) . It contains antibody to both I-A k-and I-jk-encoded antigens; I-B k, Qa, and Tla activity were not observed (10) . Experiments are in progress to determine which antiserum component(s) are necessary to bring about non-MH(2-Tc induction.
Since the advent of transplantation, immunogeneticists have questioned the basis of phenomenological distinctions between major and minor transplantation antigens. One hypothesis to explain some characteristic immunological differences between these antigens suggests that Tc development is subject to suppressive and enhancing regulatory influences; strong and weak antigens might then differ primarily in the overall balance between such regulatory mechanisms that they elicit and, therefore, in their ability to induce To. The results presented here can be interpreted in view of this hypothesis by suggesting that anti-Ia serum plus (2 might remove from the responding cell population a cellular component of a non-MH(2-antigen-activated suppressive mechanism, permitting unimpeded non-MH(2-T~ generation in antigenstimulated cultures (S. M. Macphail and F. H. Bach. (2ytotoxicity and suppression induced by in vitro responses to non-H-2 histocompatibility antigens. Manuscript in preparation.). This interpretation is strengthened by two lines of experimental evidence. First, I-J-antigen-bearing suppressor T cells have been demonstrated in several systems (14, 15) . Second, lymphocytes from non-MH(2-antigen-primed donors produce an ML(2 proliferation-suppressing factor (16) and block the differentiation of MH(2-specific memory T~ when these are restimulated with antigen in vitro (17) . If this interpretation is correct, and we regard it as a likely mechanism, this would be the first demonstration of both suppressor cells in the cell-mediated immune response (To) to non-MHC-antigens, and the existance of Ia-antigen-bearing, unprimed suppressor cells in vitro.
Other mechanisms by which anti-Ia serum and C may function cannot be ruled out. For instance, anti-Ia antibody may activate a dormant helper cell, or deliver a second requisite signal to a non-MHC-specific Tc precursor. Further experimentation should permit us to distinguish which of these possibilities is correct.
Summary
The results presented in this paper demonstrate that responding cells that remain after anti-Ia serum plus complement (C) treatment generate a highly significant in vitro cytotoxic response against minor histocompatibility complex antigens. The cytotoxic response appears to be antigen specific in that target cells of strains other than the sensitizing strain are not lysed, or lysed to a lesser extent. The cytotoxic cells are susceptible to anti-Thy-1 plus C lysis. Anti-Ia serum may function by removing an unprimed suppressor cell, although other mechanisms cannot be ruled out.
